ArticleJournal of biomolecular NMR2026
AMIGO - Guided assignment of
Article in Journal of biomolecular NMR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the last 20 years, the number of large proteins accessible to protein-NMR analysis has increased significantly due to the development of selective [1H,13C]-methyl labelling techniques in combination with methyl-TROSY based NMR experiments. Structure-based strategies for the assignment of [¹H,¹³C]-methyl groups rely on comparing spatial constraints derived from methyl–methyl NOEs to a known three-dimensional structure of the protein of interest. Cross peaks in methyl-TROSY spectra are assigned to specific methyl groups by matching methyl–methyl NOEs, as observed for example in 4D HMQC-NOESY-HMQC spectra, with distances derived from a structural model. This process is commonly referred to as a “methyl walk”. Here, we present AMIGO (Automated Methyl assignment via Iterative Graph Optimization), a novel assignment algorithm that formalises the intuitive methyl walk procedure by constructing graphs with nodes representing specific methyl groups and edges reflecting methyl-methyl NOEs or short methyl-methyl distances in a model. “Building blocks” consisting of nodes and edges are then generated to reconcile structure-based and NOE-based graphs. Assignments are achieved through permutation and concatenation of individual “building blocks” in a modular fashion, enabling efficient computation even for large proteins. Additional experimental restraints, such as paramagnetic relaxation enhancements (PREs) or pseudocontact shifts (PCSs), can be integrated to validate and extend the assignments. The performance of AMIGO was validated using 11 proteins that had previously been assigned and 32 NOE networks that had been generated synthetically.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.